QYResearch’s May 2026 global non-woven fabric mask industry report verifies the worldwide non-woven mask market size hits USD 128.7 billion in 2026, with ordinary disposable medical masks maintaining a steady average CAGR of 4.2% globally; by contrast, herbal functional masks stand as the fastest-growing niche category at an annual growth rate of 21.3%, backed by surging global demand for value-added protective PPE beyond basic particle filtration. Per Frost & Sullivan’s 2026 Southeast Asia healthcare analysis, the SEA full mask market exceeds USD 1.9 billion this year; IndexBox official May 2026 import statistics confirm Latin American finished disposable mask import dependency ranges between 70%–80%, with most finished protective commodities imported from certified Chinese manufacturers. Driven by year-round tropical pollen outbreaks and frequent seasonal upper respiratory ailments across Mexico, Brazil and Peru, retail turnover of herbal functional masks in local chain pharmacies rises over 35% year-on-year in H1 2026.

Spurred by consumers’ rising preference for multi-effect protective masks combining filtration and mild respiratory care, plant-infused functional masks have turned into a core investment hotspot across the global PPE industry in 2026. Replacing the incorrect T/CAMDI042-2026, China’s valid industry standard for anti-pathogenic masks is T/CIAA 003-2020 Antibacterial Disposable Face Mask, which has greatly lifted the product quality benchmark for domestic functional mask export and improved Chinese manufacturers’ overseas competitiveness. Statistics from China Chamber of Commerce for Import and Export of Light Industrial Products show China’s outbound shipment value of functional medical masks grows 18.7% YoY during the first five months of 2026; meanwhile the RCEP zero-tariff policy continuously cuts cross-border tariff costs for shipments to Indonesia, Vietnam and Thailand, further boosting China-made herbal mask penetration in Southeast Asian retail channels.

As a China-based R&D-driven top PPE producer, Taizhi Medical independently develops and launches two core patented herbal mask flagship lines: KeliTong Cough Relief Herbal Mask and BiliTong Nasal Soothing Anti-allergy Herbal Mask, which rapidly capture incremental market share in the booming global functional mask sector. Both product series adopt food-grade refined natural herbal extracts via the firm’s proprietary in-house lab formulation; third-party accredited labs complete efficacy verification confirming the masks relieve dry cough, nasal congestion and seasonal hay fever while retaining ≥95% BFE to satisfy standard medical protection requirements. All herbal mask items finish mandatory local medical registration in four key target markets: Mexico, Peru, Indonesia and Brazil, complying with respective local pharmacy access rules.

As of early June 2026, Taizhi Medical has signed exclusive distribution agreements with more than 280 regional pharmacy chains throughout Latin America and Southeast Asia. Global procurement search data tracked by Google Shopping and Amazon Business reveals quarter-on-quarter search volume for core procurement keywords: natural herbal allergy mask wholesale, cough soothing plant face mask supplier jumps 62%, directly pushing Taizhi’s monthly herbal mask export volume past 22 million pieces. To cope with climbing bulk spot orders and global customized OEM requests, the enterprise keeps expanding automated production workshops; R&D teams also tailor region-specific herbal formulas to develop new functional mask variants for Middle Eastern and African emerging pharmaceutical markets to broaden Taizhi’s global PPE layout.